Press Releases

Date	Title	Company
24-Jan-2023	French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug	AdipoPharma
24-Jan-2023	HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China	HUTCHMED
24-Jan-2023	DEFENCE’S MELANOMA TARGETED VACCINE A1-REPROGRAMMED MSC (ARM) CELL POTENCY VALIDATED	Defence Therapeutics Inc.
24-Jan-2023	BD to Highlight its Deep Commitment to Drug Delivery Innovation at Pharmapack	B3C newswire
24-Jan-2023	Biotest AG: First patient treated with Cytotect® CP Biotest in study after heart and lung transplantation	Biotest AG
23-Jan-2023	First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated	B3C newswire
23-Jan-2023	Defence Therapeutics Inc.: DEFENCE TO PRESENT AT THE 9TH ANNUAL IMMUNO-ONCOLOGY 360º SUMMIT IN NEW-YORK FEBRUARY 7-10, 2023	Defence Therapeutics Inc.
23-Jan-2023	Stifel initiates research coverage of Xlife Sciences	Xlife Sciences AG
20-Jan-2023	Charles River Edinburgh is a Top Employer UK for 2023	Charles River Edinburgh
20-Jan-2023	Hematology Drugs Market expanding growth at a CAGR of 9.2% from 2023 to 2032 \| insightSLICE	insightSLICE
20-Jan-2023	Glaucoma Surgery Devices Market Share Growth, Size Value, Trends, Regional Outlook 2023 to 2032 \| insightSLICE	insightSLICE
20-Jan-2023	Active Implantable Medical Devices Market to surge at a CAGR of 7.9% from 2023 to 2032 \| insightSLICE	insightSLICE
20-Jan-2023	Positron Emission Tomography (PET) Systems Market to Surge at a CAGR of 3.9% from 2023 to 2032 \| insightSLICE	insightSLICE
20-Jan-2023	Benchling appoints first EMEA general manager amidst rapid European growth	Benchling
20-Jan-2023	Ophthalmology Drugs Market accelerating at a CAGR of 7.2% from 2023 to 2032 \| insightSLICE	insightSLICE
20-Jan-2023	New COVID & Flu Dual Test Launches In The UK To Take Pressures Off The NHS	2San
20-Jan-2023	Evaxion receives FDA fast-track designation for personalized cancer immunotherapy	Evaxion Biotech A/S
20-Jan-2023	The Lancet Neurology publishes results from Minoryx Therapeutics Phase 2/3 ADVANCE clinical trial of leriglitazone in X-linked Adrenoleukodystrophy	Minoryx Therapeutics
20-Jan-2023	TrakCel and AmerisourceBergen expand platform integration to facilitate patient care coordination for cell and gene therapies	TrakCel
20-Jan-2023	BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA	BeiGene